[PDF][PDF] 肿瘤相关静脉血栓栓塞症的人群特征分析
邹海， 李方方， 张忠伟， 朱彪 - 临床内科杂志, 2023 - lcnkzz.com
·论著摘要· Page 1 betes mellitus from nurses’ perspective using the delphi method[J]. Disabil
Rehabil,2020,44(2):1⁃9. [2] Aragón⁃Sánchez J,Víquez⁃Molina G,López⁃Valverde ME,et al …
Rehabil,2020,44(2):1⁃9. [2] Aragón⁃Sánchez J,Víquez⁃Molina G,López⁃Valverde ME,et al …
The growing role of artificial intelligence and of wearable devices in the management of arrhythmias
F Crea - European Heart Journal, 2021 - academic.oup.com
Artificial intelligence (AI) is being applied in various fields of cardiology. The primary
advantage of AI is its ability to discover features of certain data that cannot be discovered …
advantage of AI is its ability to discover features of certain data that cannot be discovered …
Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer
Y Qin, L Zhang, X Liang, X Sun… - Clinical and Applied …, 2023 - journals.sagepub.com
Lung cancer is the leading cause of cancer-related mortality worldwide with an increasing
incidence in many countries. There were few studies on arterial and venous …
incidence in many countries. There were few studies on arterial and venous …
Challenges of antithrombotic treatment in high-risk populations and a fond farewell to CKMB
F Crea - European Heart Journal, 2021 - academic.oup.com
This Focus Issue on thrombosis and antithrombotic treatment contains a State of the Art
Review article entitled 'Antithrombotic therapy in diabetes: which, when, and for how …
Review article entitled 'Antithrombotic therapy in diabetes: which, when, and for how …
[PDF][PDF] To ards optimal use of antithrombotic therap of people ith cancer at the end of life: a research protocol for the de elopment and implementation of the SERENIT …
SIR Noble - Thrombosis Research, 2023 - scholarlypublications …
Background: Even though antithrombotic therapy has probably little or even negative effects
on the well-being of people with cancer during their last year of life, deprescribing …
on the well-being of people with cancer during their last year of life, deprescribing …
Focus issue on vascular biology and medicine spanning from management of stroke to new therapeutic targets in aortic dissection and pulmonary hypertension
F Crea - European Heart Journal, 2023 - academic.oup.com
This Focus Issue on vascular biology and medicine contains a State of the Art Review article
entilted 'Acute ischaemic stroke: recent advances in reperfusion treatment'by Petr Widimsky …
entilted 'Acute ischaemic stroke: recent advances in reperfusion treatment'by Petr Widimsky …
Growth differentiation factor-15: a novel biomarker for predicting risk of venous thromboembolism and bleeding in patients with cancer
S Nopp, I Pabinger - Thrombosis and Haemostasis, 2022 - thieme-connect.com
Risk of venous thromboembolism (VTE) is elevated in patients with cancer1 and based on
the findings from the CASSINI and AVERT trials, guidelines now suggest primary …
the findings from the CASSINI and AVERT trials, guidelines now suggest primary …
[HTML][HTML] 利伐沙班对预防肺癌相关肺血栓栓塞的研究进展
杨玉婷， 杨华 - Advances in Clinical Medicine, 2021 - hanspub.org
肺血栓栓塞症(pulmonary thromboembolism, PTE) 是肺癌的严重相关并发症之一,
也是肺癌患者死亡的主要原因之一. 新型口服抗凝药利伐沙班, 是国内上市最早的直接因子Xa …
也是肺癌患者死亡的主要原因之一. 新型口服抗凝药利伐沙班, 是国内上市最早的直接因子Xa …
Intersecting care through specialized pharmacists: A case report of residency rotation focused on the new horizon of cardio-oncology
L Einsfeld, I do Canto Olegário, ML Fagundes - Currents in Pharmacy …, 2023 - Elsevier
Background and purpose Cardio-oncology is a nascent discipline in the synergy of clinical
cardiology and oncology, aiming to improve antineoplastic therapies, whilst minimizing …
cardiology and oncology, aiming to improve antineoplastic therapies, whilst minimizing …
Antithrombin activity and association with risk of thrombosis and mortality in patients with cancer
Venous and arterial thromboembolism (VTE/ATE) are common complications in cancer
patients. Antithrombin deficiency is a risk factor for thrombosis in the general population, but …
patients. Antithrombin deficiency is a risk factor for thrombosis in the general population, but …